Evaxion A (EVAX) Non-Current Debt (2021 - 2025)
Evaxion A (EVAX) posted Non-Current Debt of $5.3 million for Q4 2025, down 40.79% on a QoQ basis from $9.0 million in Q2 2025, and down 33.23% year-over-year from $8.0 million in Q4 2024.
Evaxion A (EVAX) Non-Current Debt (2021 - 2025) Analysis & Trends
Evaxion A's Non-Current Debt history runs 5 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- Quarterly Non-Current Debt fell 33.23% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (down 33.23% YoY) and the FY2025 annual result came in at $5.3 million, down 33.23% from the prior year.
- Non-Current Debt was $5.3 million for Q4 2025 at Evaxion A, down from $9.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $9.0 million in Q2 2025 and bottomed at $1.0 million in Q4 2021.
- A 5-year average of $6.6 million and a median of $7.9 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 653.26% — and 2025, when it sank 33.23%.
- Evaxion A's Non-Current Debt stood at $1.0 million in 2021, then jumped by 653.26% to $7.9 million in 2022, then grew by 7.95% to $8.5 million in 2023, then dropped by 5.67% to $8.0 million in 2024, then sank by 33.23% to $5.3 million in 2025.
- Business Quant data shows EVAX's Non-Current Debt at $5.3 million in Q4 2025, $9.0 million in Q2 2025, and $8.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 105.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 842.92 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.35 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Dec 31, 2023 | 8.49 Mn |
| Jun 30, 2023 | 8.08 Mn |
| Dec 31, 2022 | 7.86 Mn |
| Jun 30, 2022 | 7.34 Mn |
| Mar 31, 2022 | 7.72 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 1.10 Mn |